Doctors vs. Bureaucrats: Who Should Control Patient Care

Published March 16, 2026

During COVID-19, physicians who questioned official mandates on lockdowns, school closures, and vaccines faced censorship and professional retaliation — silencing scientific debate at the moment it mattered most. As a result, trust in doctors and hospitals fell from 72% in 2019 to 40% by 2024.

The connection is direct: when government mandates displace physician judgment and informed consent, public trust erodes. Rebuilding it requires restoring the primacy of doctor-patient decision-making and the freedom to follow evidence over directives.

Learn more from Scott Atlas:

  • Read "Physician Autonomy And Free Speech: Essential For Effective Public Health Response" by Scott Atlas here.
  • Read "Unwitting victims" by Scott Atlas here.
  • Read "Understanding and Saving Gen Z To Save America" by Scott Atlas here.

Visit Scott Atlas's profile here.

__________

The opinions expressed in this video are those of the authors and do not necessarily reflect the opinions of the Hoover Institution or Stanford University.

© 2026 by the Board of Trustees of Leland Stanford Junior University.

 

Cast

Scott W. Atlas

Scott W. Atlas

Related

Videos

Why Does Medicare Pay Different Prices For The Same Procedures? Site Neutral Payments W/Tom Church And Charlie Katebi

Hoover Institution fellow Tom Church talks with Charlie Katebi of the America First Policy Institute about site neutral policy in Medicare.

September 25, 2026

Articles

Reimagining Quality Measurement In Medicare

Medicare is comprised of three primary models: Fee For Service Medicare, Accountable Care Organizations, and Medicare Advantage plans. Each model has a distinct quality measurement system, with disparate measures that do not cross programs, making cross-program performance assessment challenging. 

September 21, 2026

Congressional Testimony

Examining Healthcare Markets: Fraud And Competition

(23:52) Hoover Institution fellow Dr. Brian Miller testifies in front of the House Judiciary Subcommittee on the Administrative State, Regulatory Reform, and Antitrust in a hearing titled "Examining Healthcare Markets: Fraud and Competition."

September 14, 2026